Biotech

All Articles

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, taking up the ...

Achilles splashes cell treatment course, braces for cutbacks after missing out on 'office feasibility' goals

.Achilles Therapies has actually destroyed its method. The British biotech is knocking off on its ow...

Aligos heralds stage 2 MASH succeed, slashing liver excess fat up to 46%

.Aligos Therapies is actually trumpeting a midstage gain in metabolic-dysfunction associated steatoh...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating new antifungals has acquired a significant improvement from th...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Having currently scooped up the united state liberties to Capricor Rehabs' late-stage Duchenne musc...

FDA fragments adcomm for Applied's uncommon illness medication

.After dismissing the decision meeting for Applied Therapeutics' metabolic disorder medicine govores...

Novo inks $600M NanoVation offer to study genetic medicines ex-liver

.Novo Nordisk is proceeding its own push into hereditary medicines, accepting to compensate NanoVati...

Innovent web links cytokine to colon cancer responses

.Innovent Biologics has actually produced the case that its checkpoint inhibitor-cytokine combinatio...

Merck, Daiichi ADC hits objective in period 3 bronchi cancer research

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina grows AI center along with collab to select cancer targets

.Five months after Rakovina Rehabs pivoted towards expert system, the cancer-focused biotech has act...